Terms: = Bone cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
97 results:
1. Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
2. Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and pten/PI3K/AKT pathway in osteosarcoma cells.
Yang J; Jiang H; Fu Q; Qin H; Li Y; Liu M
J Photochem Photobiol B; 2023 Dec; 249():112814. PubMed ID: 37956614
[TBL] [Abstract] [Full Text] [Related]
3. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
4. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the pten/PI3K/AKT pathway.
Tong Z; Shen Y; Yuan Q; Yu H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
[TBL] [Abstract] [Full Text] [Related]
5. A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance.
Doghish AS; Hegazy M; Ismail A; El-Mahdy HA; Elsakka EGE; Elkhawaga SY; Elkady MA; Yehia AM; Abdelmaksoud NM; Mokhtar MM
Pathol Res Pract; 2023 May; 245():154442. PubMed ID: 37031532
[TBL] [Abstract] [Full Text] [Related]
6. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
7. PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.
Si Z; Shen Z; Luan F; Yan J
J Orthop Surg Res; 2023 Feb; 18(1):132. PubMed ID: 36823640
[TBL] [Abstract] [Full Text] [Related]
8. Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in pten-negative prostate cancer by targeting plectin to focal adhesions.
Wenta T; Schmidt A; Zhang Q; Devarajan R; Singh P; Yang X; Ahtikoski A; Vaarala M; Wei GH; Manninen A
Oncogene; 2022 Jul; 41(30):3804-3820. PubMed ID: 35773413
[TBL] [Abstract] [Full Text] [Related]
9. The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Liu AJ; Kosiorek HE; Ueberroth BE; Jaeger E; Ledet E; Kendi AT; Tzou K; Quevedo F; Choo R; Moore CN; Ho TH; Singh P; Keole SR; Wong WW; Sartor O; Bryce AH
Prostate; 2022 Sep; 82(12):1202-1209. PubMed ID: 35652618
[TBL] [Abstract] [Full Text] [Related]
10. Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review.
Masuda T; Kosaka T; Nakamura K; Hongo H; Yuge K; Nishihara H; Oya M
BMC Med Genomics; 2022 May; 15(1):118. PubMed ID: 35598018
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate cancer.
Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
[TBL] [Abstract] [Full Text] [Related]
12. PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma.
Chen C; Guo Y; Huang Q; Wang B; Wang W; Niu J; Lou J; Xu J; Ren T; Huang Y; Guo W
Cancer Lett; 2022 Jun; 536():215660. PubMed ID: 35318116
[TBL] [Abstract] [Full Text] [Related]
13. Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition.
Karabacak NM; Zheng Y; Dubash TD; Burr R; Micalizzi DS; Wittner BS; Lin M; Wiley DF; Comaills V; Emmons E; Niederhoffer KL; Ho U; Ukleja J; Che D; Stowe H; Nieman LT; Haas W; Stott SL; Lawrence MS; Ting DT; Miyamoto DT; Haber DA; Toner M; Maheswaran S
Cancer Res; 2022 Mar; 82(6):1084-1097. PubMed ID: 35045985
[TBL] [Abstract] [Full Text] [Related]
14. The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells.
Tan B; Yuan Z; Zhang Q; Xiqiang X; Dong J
J Appl Biomed; 2021 Dec; 19(4):190-201. PubMed ID: 34907738
[TBL] [Abstract] [Full Text] [Related]
15. Alteration of PPAR-GAMMA (PPARG; PPARγ) and pten gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells.
Esmaeili S; Salari S; Kaveh V; Ghaffari SH; Bashash D
Mol Genet Genomic Med; 2021 Nov; 9(11):e1818. PubMed ID: 34549887
[TBL] [Abstract] [Full Text] [Related]
16. Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting pten.
Wang M; Zhao M; Guo Q; Lou J; Wang L
Exp Cell Res; 2021 Nov; 408(1):112834. PubMed ID: 34537206
[TBL] [Abstract] [Full Text] [Related]
17. Tetrandrine suppresses the growth of human osteosarcoma cells by regulating multiple signaling pathways.
Wang N; Yang S; Tan T; Huang Y; Chen Y; Dong C; Chen J; Luo X
Bioengineered; 2021 Dec; 12(1):5870-5882. PubMed ID: 34477474
[TBL] [Abstract] [Full Text] [Related]
18. Pharmacological mechanism of mylabris in the treatment of leukemia based on bioinformatics and systematic pharmacology.
Zhan H; Bai Y; Lv Y; Zhang X; Zhang L; Deng S
Bioengineered; 2021 Dec; 12(1):3229-3239. PubMed ID: 34224300
[TBL] [Abstract] [Full Text] [Related]
19. A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.
Arriaga JM; Panja S; Alshalalfa M; Zhao J; Zou M; Giacobbe A; Madubata CJ; Kim JY; Rodriguez A; Coleman I; Virk RK; Hibshoosh H; Ertunc O; Ozbek B; Fountain J; Jeffrey Karnes R; Luo J; Antonarakis ES; Nelson PS; Feng FY; Rubin MA; De Marzo AM; Rabadan R; Sims PA; Mitrofanova A; Abate-Shen C
Nat Cancer; 2020 Nov; 1(11):1082-1096. PubMed ID: 34085047
[TBL] [Abstract] [Full Text] [Related]
20. mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with pten-BMPR1A deletion.
Taylor H; Yerlioglu D; Phen C; Ballauff A; Nedelkopoulou N; Spier I; Loverdos I; Busoni VB; Heise J; Dale P; de Meij T; Sweet K; Cohen MC; Fox VL; Mas E; Aretz S; Eng C; Buderus S; Thomson M; Rojas I; Uhlig HH
Hum Mol Genet; 2021 Jun; 30(14):1273-1282. PubMed ID: 33822054
[TBL] [Abstract] [Full Text] [Related]
[Next]
